Correction: Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive Aspergillosis (PLoS ONE (2012) 7: 8 (e43347) DOI: 10.1371/journal.pone.0043347);Systematic review and meta-analysis of detecting Galactomannan in bronchoalveolar lavage fluid for diagnosing invasive Aspergillosis

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Zou, Mingxiang ^a   Tang, Lanhua ^a   Zhao, Shushan ^a   Zhao, Zijin ^a   Chen, Luyao ^a   Chen, Peng ^b   Huang, Zebing ^a   Li, Jun ^a   Chen, Lizhang ^a   Fan, Xuegong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOMANNAN; MANNAN;

ARTICLE; CARBOHYDRATE ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; HUMAN; INTERMETHOD COMPARISON; INVASIVE ASPERGILLOSIS; LUNG LAVAGE; POLYMERASE CHAIN REACTION; QUALITY CONTROL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; BIOSYNTHESIS; BRONCHOALVEOLAR LAVAGE FLUID; CASE CONTROL STUDY; DIAGNOSTIC TEST; INVASIVE PULMONARY ASPERGILLOSIS; META ANALYSIS; METABOLISM; ODDS RATIO; PREDICTIVE VALUE; PROBABILITY; PROCEDURES; REPRODUCIBILITY;

BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; DIAGNOSTIC TESTS, ROUTINE; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; MANNANS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROBABILITY; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84865050415     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0190459     Document Type: Erratum

References (71)

1. Del Bono V, Mikulska M, Viscoli C, (2008) Invasive aspergillosis: diagnosis, prophylaxis and treatment. Curr Opin Hematol 15: 586-593.
2. Dagenais TR, Keller NP, (2009) Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis. Clin Microbiol Rev 22: 447-465.
3. Maschmeyer G, Haas A, Cornely OA, (2007) Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients. Drugs 67: 1567-1601.
4. Baddley JW, (2011) Clinical risk factors for invasive aspergillosis. Med Mycol 49 (Suppl 1): S7-S12.
5. Reichenberger F, Habicht JM, Gratwohl A, Tamm M, (2002) Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients. Eur Respir J 19: 743-755.
6. Chamilos G, Kontoyiannis DP, (2005) Update on antifungal drug resistance mechanisms of Aspergillus fumigatus. Drug Resist Updat 8: 344-358.
7. von Eiff M, Roos N, Schulten R, Hesse M, Zuhlsdorf M, et al. (1995) Pulmonary aspergillosis: early diagnosis improves survival. Respiration 62: 341-347.
8. Rodloff C, Koch D, Schaumann R, (2011) Epidemiology and antifungal resistance in invasive candidiasis. Eur J Med Res 16: 187-195.
9. Maertens J, Theunissen K, Lodewyck T, Lagrou K, Van Eldere J, (2007) Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders. Mycoses 50 (Suppl 1): 2-17.
10. Zedek DC, Miller MB, (2006) Use of galactomannan enzyme immunoassay for diagnosis of invasive aspergillosis in a tertiary-care center over a 12-month period. J Clin Microbiol 44: 1601.
11. Hope WW, Walsh TJ, Denning DW, (2005) Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 5: 609-622.
12. Guo YL, Chen YQ, Wang K, Qin SM, Wu C, et al. (2010) Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review. Chest 138: 817-824.
13. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, et al. (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34: 7-14.
14. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, et al. (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46: 1813-1821.
15. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, et al. (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155: 529-536.
16. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, et al. (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem 49: 1-6.
17. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM, (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56: 1129-1135.
18. Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP, (2009) Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis 9: 89-96.
19. Lu Y, Chen YQ, Guo YL, Qin SM, Wu C, et al. (2011) Diagnosis of invasive fungal disease using serum (1->3)-beta-D-glucan: a bivariate meta-analysis. Intern Med 50: 2783-2791.
20. Deeks JJ, (2001) Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ 323: 157-162.
21. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
22. Jackson D, White IR, Thompson SG, (2010) Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med 29: 1282-1297.
23. Bergeron A, Porcher R, Menotti J, Poirot JL, Chagnon K, et al. (2012) Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients. J Clin Microbiol 50: 823-830.
24. D'Haese J, Theunissen K, Vermeulen E, Schoemans H, De Vlieger G, et al. (2012) Galactomannan detection in bronchoalveolar lavage fluid of patients at risk of invasive pulmonary aspergillosis: analytical and clinical validity. J Clin Microbiol.
25. Acosta J, Catalan M, del Palacio-Perez-Medel A, Lora D, Montejo JC, et al. (2011) A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1->3)-beta-d-glucan chromogenic assay in serum samples. Clin Microbiol Infect 17: 1053-1060.
26. Hadrich I, Mary C, Makni F, Elloumi M, Dumon H, et al. (2011) Comparison of PCR-ELISA and Real-Time PCR for invasive aspergillosis diagnosis in patients with hematological malignancies. Med Mycol 49: 489-494.
27. Luong ML, Clancy CJ, Vadnerkar A, Kwak EJ, Silveira FP, et al. (2011) Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients. Clin Infect Dis 52: 1218-1226.
28. Nguyen MH, Leather H, Clancy CJ, Cline C, Jantz MA, et al. (2011) Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients. Biol Blood Marrow Transplant 17: 1043-1050.
29. Torelli R, Sanguinetti M, Moody A, Pagano L, Caira M, et al. (2011) Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay. J Clin Microbiol 49: 4273-4278.
30. Racil Z, Kocmanova I, Toskova M, Buresova L, Weinbergerova B, et al. (2011) Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance. Int J Infect Dis 15: e874-881.
31. Leng Y, Chen WM, Liu JW, (2011) Feasibility of galactomannan assay in bronchoalveolar lavage fluid in diagnosis of hematologic malignancy patients with invasive fungal infections. Chinese Journal Of Hematology 32: 551-552.
32. Lin QC, Zhang XB, Lin X, Lin YL, Yang B, et al. (2011) The value of galactomannan detection in bronchoalveolar lavage fluid in the diagnosis of invasive pulmonary aspergillosis in elderly patients with lung diseases. Chinese Journal of Geriatrics 30: 732-736.
33. Bergeron A, Belle A, Sulahian A, Lacroix C, Chevret S, et al. (2010) Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Chest 137: 410-415.
34. Park SY, Lee SO, Choi SH, Sung H, Kim MN, et al. (2010) Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Infect 61: 492-498.
35. Hsu LY, Ding Y, Phua J, Koh LP, Chan DS, et al. (2010) Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients. BMC Infect Dis 10: 44.
36. Danpornprasert P, Foongladda S, Tscheikuna J, (2010) Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis. J Med Assoc Thai 93 (Suppl 1): S86-93.
37. Paugam A, Baixench MT, Lebuisson A, Dupouy-Camet J, (2010) Diagnosis of invasive pulmonary aspergillosis: value of bronchoalveolar lavage galactomannan for immunocompromised patients. Pathol Biol (Paris) 58: 100-103.
38. Pasqualotto AC, Xavier MO, Sanchez LB, de Oliveira Costa CD, Schio SM, et al. (2010) Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid. Transplantation 90: 306-311.
39. Luong ML, Filion C, Labbe AC, Roy J, Pepin J, et al. (2010) Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies. Diagn Microbiol Infect Dis 68: 132-139.
40. Jin X, Chen JK, Yu N, Zuo XH, Yin XY, et al. (2010) Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis. Chinese Journal Of Health Laboratory Technology 20: 2900-2902.
41. Maertens J, Maertens V, Theunissen K, Meersseman W, Meersseman P, et al. (2009) Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis 49: 1688-1693.
42. Desai R, Ross LA, Hoffman JA, (2009) The role of bronchoalveolar lavage galactomannan in the diagnosis of pediatric invasive aspergillosis. Pediatr Infect Dis J 28: 283-286.
43. Frealle E, Decrucq K, Botterel F, Bouchindhomme B, Camus D, et al. (2009) Diagnosis of invasive aspergillosis using bronchoalveolar lavage in haematology patients: influence of bronchoalveolar lavage human DNA content on real-time PCR performance. Eur J Clin Microbiol Infect Dis 28: 223-232.
44. Kimura S, Odawara J, Aoki T, Yamakura M, Takeuchi M, et al. (2009) Detection of sputum Aspergillus galactomannan for diagnosis of invasive pulmonary aspergillosis in haematological patients. Int J Hematol 90: 463-470.
45. Meersseman W, Lagrou K, Maertens J, Wilmer A, Hermans G, et al. (2008) Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 177: 27-34.
46. Shahid M, Malik A, Bhargava R, (2008) Bronchogenic carcinoma and secondary aspergillosis-common yet unexplored: evaluation of the role of bronchoalveolar lavage-polymerase chain reaction and some nonvalidated serologic methods to establish early diagnosis. Cancer 113: 547-558.
47. Husain S, Clancy CJ, Nguyen MH, Swartzentruber S, Leather H, et al. (2008) Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid. Clin Vaccine Immunol 15: 1760-1763.
48. Clancy CJ, Jaber RA, Leather HL, Wingard JR, Staley B, et al. (2007) Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J Clin Microbiol 45: 1759-1765.
49. Nguyen MH, Jaber R, Leather HL, Wingard JR, Staley B, et al. (2007) Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts. J Clin Microbiol 45: 2787-2792.
50. Musher B, Fredricks D, Leisenring W, Balajee SA, Smith C, et al. (2004) Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol 42: 5517-5522.
51. Becker MJ, Lugtenburg EJ, Cornelissen JJ, Van Der Schee C, Hoogsteden HC, et al. (2003) Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br J Haematol 121: 448-457.
52. Sanguinetti M, Posteraro B, Pagano L, Pagliari G, Fianchi L, et al. (2003) Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol 41: 3922-3925.
53. Gerlinger MP, Rousselot P, Rigaudeau S, Billon C, Touratier S, et al. (2012) False positive galactomannan Platelia due to piperacillin-tazobactam. Med Mal Infect 42: 10-14.
54. Boonsarngsuk V, Niyompattama A, Teosirimongkol C, Sriwanichrak K, (2010) False-positive serum and bronchoalveolar lavage Aspergillus galactomannan assays caused by different antibiotics. Scand J Infect Dis 42: 461-468.
55. Saghrouni F, Ben Youssef Y, Gheith S, Bouabid Z, Ben Abdeljelil J, et al. (2011) Twenty-nine cases of invasive aspergillosis in neutropenic patients. Med Mal Infect 41: 657-662.
56. Husain S, Paterson DL, Studer SM, Crespo M, Pilewski J, et al. (2007) Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation 83: 1330-1336.
57. Hadrich I, Makni F, Cheikhrouhou F, Neji S, Amouri I, et al. (2011) Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis. Pathol Biol (Paris).
58. Verweij PE, Latge JP, Rijs AJ, Melchers WJ, De Pauw BE, et al. (1995) Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies. J Clin Microbiol 33: 3150-3153.
59. Park SY, Lee SO, Choi SH, Jeong JY, Sung H, et al. (2011) Serum and bronchoalveolar lavage fluid galactomannan assays in patients with pulmonary aspergilloma. Clin Infect Dis 52: e149-152.
60. Wang J (2007) Study on early diagnosis of invasive aspergillosis in patients with hematological disease [Research Article]. Suzhou: Suzhou University. 51 p.
61. Burgos A, Zaoutis TE, Dvorak CC, Hoffman JA, Knapp KM, et al. (2008) Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases. Pediatrics 121: e1286-1294.
62. Francesconi A, Kasai M, Petraitiene R, Petraitis V, Kelaher AM, et al. (2006) Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis. J Clin Microbiol 44: 2475-2480.
63. Drummond MF, Richardson WS, O'Brien BJ, Levine M, Heyland D, (1997) Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 277: 1552-1557.
64. Foy PC, van Burik JA, Weisdorf DJ, (2007) Galactomannan antigen enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 13: 440-443.
65. Pfeiffer CD, Fine JP, Safdar N, (2006) Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 42: 1417-1427.
66. Hope WW, Kruhlak MJ, Lyman CA, Petraitiene R, Petraitis V, et al. (2007) Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy. J Infect Dis 195: 455-466.
67. Mennink-Kersten MA, Donnelly JP, Verweij PE, (2004) Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 4: 349-357.
68. Wheat LJ, Walsh TJ, (2008) Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay. Eur J Clin Microbiol Infect Dis 27: 245-251.
69. Dalle F, Charles PE, Blanc K, Caillot D, Chavanet P, et al. (2005) Cryptococcus neoformans Galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus Galactomannan. J Clin Microbiol 43: 2929-2931.
70. Song F, Khan KS, Dinnes J, Sutton AJ, (2002) Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. Int J Epidemiol 31: 88-95.
71. Kradin RL, Mark EJ, (2008) The pathology of pulmonary disorders due to Aspergillus spp. Arch Pathol Lab Med 132: 606-614.